Ec. Spoelstra et al., THE MULTIDRUG-RESISTANCE-REVERSER VERAPAMIL INTERFERES WITH CELLULAR P-GLYCOPROTEIN-MEDIATED PUMPING OF DAUNORUBICIN AS A NON-COMPETING SUBSTRATE, European journal of biochemistry, 221(1), 1994, pp. 363-373
We examined P-glycoprotein-mediated verapamil transport, using two dru
g-sensitive and multidrug resistant cell-line couples, i.e. A2780, 278
0(AD) and SW-1573, SW-1573/1R500. The interaction of H-3-labeled verap
amil with cells was measured using a flow-through system. The verapami
l-containing medium was pumped over the cells and monitored on-line fo
r radioactivity. In the P-glycoprotein-expressing cells, verapamil acc
umulation was increased by vinblastine and some known multidrug resist
ant (MDR) modifiers. Subsequent removal of these modifiers caused rele
ase of verapamil into the medium against a verapamil concentration gra
dient. In this manner, we obtained evidence that verapamil is actively
transported by the MDR-related P-glycoprotein. Using the flow-through
system, we also exposed the cells to flowing culture medium containin
g daunorubicin, and measured the inhibition of daunorubicin efflux by
verapamil. We found that, although the active efflux of daunorubicin w
as maximally blocked by verapamil short-term, longer-term active efflu
x of daunorubicin resumed. At a daunorubicin concentration in the flow
ing medium of 5 mu M, increasing the verapamil concentration resulted
in the same short-term effects, but in a significantly longer period o
f a maximal inhibition of daunorubicin efflux from the cells. At a dau
norubicin concentration of 20 mu M, increasing the verapamil concentra
tion affected neither the short-term nor the long-term effects. These
and other observations are in agreement with a model in which daunorub
icin and verapamil are non-competing substrates for P-glycoprotein. In
conclusion, we obtained evidence that verapamil is actively transport
ed by the MDR-related P-glycoprotein and that verapamil and daunorubic
in are non-competing substrates for P-glycoprotein. Consequently, the
effectiveness of verapamil as an MDR antagonist may be compromised bec
ause it is extruded by P-glycoprotein.